Singular Genomics Systems Statistics
Total Valuation
OMIC has a market cap or net worth of $29.20 million. The enterprise value is -$70.05 million.
| Market Cap | 29.20M |
| Enterprise Value | -70.05M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OMIC has 73.93 million shares outstanding. The number of shares has increased by 2.32% in one year.
| Shares Outstanding | 73.93M |
| Shares Change (YoY) | +2.32% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 13.94% |
| Owned by Institutions (%) | 48.41% |
| Float | 46.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.03 |
| Forward PS | 11.83 |
| PB Ratio | 0.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.51, with a Debt / Equity ratio of 0.42.
| Current Ratio | 10.51 |
| Quick Ratio | 9.58 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -85.12 |
Financial Efficiency
Return on equity (ROE) is -45.30% and return on invested capital (ROIC) is -40.43%.
| Return on Equity (ROE) | -45.30% |
| Return on Assets (ROA) | -33.30% |
| Return on Capital (ROIC) | -40.43% |
| Revenue Per Employee | $11,416 |
| Profits Per Employee | -$371,843 |
| Employee Count | 255 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.73% in the last 52 weeks. The beta is 1.40, so OMIC's price volatility has been higher than the market average.
| Beta (1Y) | 1.40 |
| 52-Week Price Change | -64.73% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 35.95 |
| Average Volume (30 Days) | 115,296 |
Short Selling Information
The latest short interest is 732,285, so 0.99% of the outstanding shares have been sold short.
| Short Interest | 732,285 |
| Short Previous Month | 813,510 |
| Short % of Shares Out | 0.99% |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 7.71 |
Income Statement
In the last 12 months, OMIC had revenue of $2.91 million and -$94.82 million in losses. Loss per share was -$1.30.
| Revenue | 2.91M |
| Gross Profit | -558,000 |
| Operating Income | -102.80M |
| Pretax Income | -94.82M |
| Net Income | -94.82M |
| EBITDA | -86.50M |
| EBIT | -93.72M |
| Loss Per Share | -$1.30 |
Balance Sheet
The company has $174.54 million in cash and $75.29 million in debt, giving a net cash position of $99.25 million or $1.34 per share.
| Cash & Cash Equivalents | 174.54M |
| Total Debt | 75.29M |
| Net Cash | 99.25M |
| Net Cash Per Share | $1.34 |
| Equity / Book Value | 179.01M |
| Book Value Per Share | 2.42 |
| Working Capital | 173.94M |
Cash Flow
In the last 12 months, operating cash flow was -$73.65 million and capital expenditures -$970,000, giving a free cash flow of -$74.62 million.
| Operating Cash Flow | -73.65M |
| Capital Expenditures | -970,000 |
| Free Cash Flow | -74.62M |
| FCF Per Share | -$1.03 |
Margins
Gross margin is -19.17%, with operating and profit margins of -3,531.47% and -3,257.30%.
| Gross Margin | -19.17% |
| Operating Margin | -3,531.47% |
| Pretax Margin | -3,257.30% |
| Profit Margin | -3,257.30% |
| EBITDA Margin | -2,971.35% |
| EBIT Margin | -3,219.48% |
| FCF Margin | -2,563.28% |
Dividends & Yields
OMIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.32% |
| Shareholder Yield | -2.32% |
| Earnings Yield | -324.71% |
| FCF Yield | -255.52% |
Analyst Forecast
The average price target for OMIC is $0.68, which is 72.15% higher than the current price. The consensus rating is "Hold".
| Price Target | $0.68 |
| Price Target Difference | 72.15% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OMIC has an Altman Z-Score of -1.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.95 |
| Piotroski F-Score | 2 |